Literature DB >> 17510485

Abducens palsy and Sjogren's syndrome induced by pegylated interferon therapy.

Akio Oishi, Kazuaki Miyamoto, Satoshi Kashii, Nagahisa Yoshimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17510485      PMCID： PMC1955617          DOI： 10.1136/bjo.2006.110494

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Retinopathy is not the only ocular symptom: myasthenia gravis in association with interferon therapy.

Authors:  A Oishi; K Miyamoto; S Kashii; N Yoshimura
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

3.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

Review 4.  Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

Authors:  F L Dumoulin; L Leifeld; T Sauerbruch; U Spengler
Journal:  Biomed Pharmacother       Date:  1999-06       Impact factor: 6.529

5.  Abducens nerve enhancement demonstrated by multiplanar reconstruction of contrast-enhanced three-dimensional MRI.

Authors:  T Hosoya; M Adachi; K Yamaguchi; K Yamaguchi; T Kato; Y Sugai
Journal:  Neuroradiology       Date:  2001-04       Impact factor: 2.804

6.  Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.

Authors:  Louis d'Alteroche; Samuel Majzoub; Anne-Isabelle Lecuyer; Marie-Paule Delplace; Yannick Bacq
Journal:  J Hepatol       Date:  2005-08-18       Impact factor: 25.083

7.  Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.

Authors:  Y Fukumoto; T Shigemitsu; N Kajii; R Omura; T Harada; K Okita
Journal:  Intern Med       Date:  1994-10       Impact factor: 1.271
  7 in total
  4 in total

1.  Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.

Authors:  Zana Brkic; Naomi I Maria; Cornelia G van Helden-Meeuwsen; Joop P van de Merwe; Paul L van Daele; Virgil A Dalm; Manon E Wildenberg; Wouter Beumer; Hemmo A Drexhage; Marjan A Versnel
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

Review 2.  Ocular side effects of biological agents in oncology: what should the clinician be aware of?

Authors:  Tobias Hager; B Seitz
Journal:  Onco Targets Ther       Date:  2013-12-24       Impact factor: 4.147

3.  Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma.

Authors:  Michele Colaci; Giulia Cassone; Andreina Manfredi; Marco Sebastiani; Dilia Giuggioli; Clodoveo Ferri
Journal:  Case Rep Neurol Med       Date:  2014-08-05

Review 4.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.